A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says.
Baricitinib safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes, researchers reported Friday at the annual meeting of the European Association for the Study of Diabetes in Vienna.
Further, patients' diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.
"This is a really exciting step forward," lead researcher Michaela Waibel, an immunologist and project manager at St. Vincent's Institute of Medical Research in Australia, said in a news release.
Related
